Suppr超能文献

TMEM127 是人类肿瘤抑制因子,也是 mTORC1 溶酶体营养感应复合物的组成部分。

The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.

机构信息

Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

出版信息

Hum Mol Genet. 2018 May 15;27(10):1794-1808. doi: 10.1093/hmg/ddy095.

Abstract

The TMEM127 tumor suppressor gene encodes a transmembrane protein of unknown function mutated in pheochromocytomas and, rarely, in renal cancers. Tumors with inactivating TMEM127 mutations have increased mTORC1 signaling by undefined mechanisms. Here we report that TMEM127 interacts with the lysosome-anchored complex comprised of Rag GTPases, the LAMTOR pentamer (or 'ragulator') and vATPase, which controls amino acid-mediated mTORC1 activation. We found that under nutrient-rich conditions TMEM127 expression reduces mTORC1 recruitment to Rags. In addition, TMEM127 interacts with LAMTOR in an amino acid-dependent manner and decreases the LAMTOR1-vATPase association, while TMEM127-vATPase binding requires intact lysosomal acidification but is amino acid independent. Conversely, both murine and human cells lacking TMEM127 accumulate LAMTOR proteins in the lysosome. Consistent with these findings, pheochromocytomas with TMEM127 mutations have increased levels of LAMTOR proteins. These results suggest that TMEM127 interactions with ragulator and vATPase at the lysosome contribute to restrain mTORC1 signaling in response to amino acids, thus explaining the increased mTORC1 activation seen in TMEM127-deficient tumors.

摘要

TMEM127 肿瘤抑制基因编码一种未知功能的跨膜蛋白,在嗜铬细胞瘤中发生突变,在肾癌中很少发生突变。具有失活 TMEM127 突变的肿瘤通过未知机制增加了 mTORC1 信号。在这里,我们报告 TMEM127 与由 Rag GTPases、LAMTOR 五聚体(或“ragulator”)和 vATPase 组成的溶酶体锚定复合物相互作用,该复合物控制氨基酸介导的 mTORC1 激活。我们发现,在营养丰富的条件下,TMEM127 的表达减少了 Rags 对 mTORC1 的募集。此外,TMEM127 以氨基酸依赖的方式与 LAMTOR 相互作用,并降低了 LAMTOR1-vATPase 结合,而 TMEM127-vATPase 结合需要完整的溶酶体酸化,但不依赖于氨基酸。相反,缺乏 TMEM127 的小鼠和人类细胞在溶酶体中积累了更多的 LAMTOR 蛋白。与这些发现一致的是,具有 TMEM127 突变的嗜铬细胞瘤中 LAMTOR 蛋白水平升高。这些结果表明,TMEM127 与 ragulator 和 vATPase 在溶酶体中的相互作用有助于抑制氨基酸对 mTORC1 信号的激活,从而解释了在 TMEM127 缺陷肿瘤中观察到的 mTORC1 激活增加。

相似文献

1
The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.
Hum Mol Genet. 2018 May 15;27(10):1794-1808. doi: 10.1093/hmg/ddy095.
2
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.
Cell Rep. 2023 Sep 26;42(9):113070. doi: 10.1016/j.celrep.2023.113070. Epub 2023 Sep 1.
3
Rag-Ragulator is the central organizer of the physical architecture of the mTORC1 nutrient-sensing pathway.
Proc Natl Acad Sci U S A. 2024 Aug 27;121(35):e2322755121. doi: 10.1073/pnas.2322755121. Epub 2024 Aug 20.
4
A Ragulator-BORC interaction controls lysosome positioning in response to amino acid availability.
J Cell Biol. 2017 Dec 4;216(12):4183-4197. doi: 10.1083/jcb.201703094. Epub 2017 Oct 9.
5
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
JAMA. 2010 Dec 15;304(23):2611-9. doi: 10.1001/jama.2010.1830.
6
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.
Cell. 2010 Apr 16;141(2):290-303. doi: 10.1016/j.cell.2010.02.024. Epub 2010 Apr 8.
8
Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling.
Science. 2017 Oct 20;358(6361):377-381. doi: 10.1126/science.aao1583. Epub 2017 Sep 21.
9
Disruption of the Rag-Ragulator Complex by c17orf59 Inhibits mTORC1.
Cell Rep. 2015 Sep 1;12(9):1445-55. doi: 10.1016/j.celrep.2015.07.052. Epub 2015 Aug 20.
10
Structural basis for the assembly of the Ragulator-Rag GTPase complex.
Nat Commun. 2017 Nov 20;8(1):1625. doi: 10.1038/s41467-017-01762-3.

引用本文的文献

4
Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma.
FEBS Open Bio. 2024 Jan;14(1):112-126. doi: 10.1002/2211-5463.13732. Epub 2023 Nov 27.
5
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.
Cell Rep. 2023 Sep 26;42(9):113070. doi: 10.1016/j.celrep.2023.113070. Epub 2023 Sep 1.
6
Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics.
bioRxiv. 2024 Apr 3:2023.06.28.546955. doi: 10.1101/2023.06.28.546955.
7
The Ragulator complex: delving its multifunctional impact on metabolism and beyond.
Inflamm Regen. 2023 May 12;43(1):28. doi: 10.1186/s41232-023-00278-2.
8
Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.
Int J Mol Sci. 2022 Jan 27;23(3):1450. doi: 10.3390/ijms23031450.
9
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers.
Cancers (Basel). 2021 Sep 14;13(18):4602. doi: 10.3390/cancers13184602.
10
San Antonio Nathan Shock Center: your one-stop shop for aging research.
Geroscience. 2021 Oct;43(5):2105-2118. doi: 10.1007/s11357-021-00417-y. Epub 2021 Jul 9.

本文引用的文献

2
LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent late endosomal positioning.
J Cell Biol. 2017 Dec 4;216(12):4199-4215. doi: 10.1083/jcb.201703061. Epub 2017 Oct 9.
4
Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling.
Science. 2017 Oct 20;358(6361):377-381. doi: 10.1126/science.aao1583. Epub 2017 Sep 21.
5
mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy.
J Clin Invest. 2017 Oct 2;127(10):3717-3729. doi: 10.1172/JCI94130. Epub 2017 Sep 5.
6
Molecular and phenotypic evaluation of a novel germline mutation with an uncommon clinical presentation.
Endocr Relat Cancer. 2017 Nov;24(11):L79-L82. doi: 10.1530/ERC-17-0359. Epub 2017 Aug 30.
7
The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway.
Cell Metab. 2017 Aug 1;26(2):301-309. doi: 10.1016/j.cmet.2017.07.001.
8
mTOR Signaling in Growth, Metabolism, and Disease.
Cell. 2017 Apr 6;169(2):361-371. doi: 10.1016/j.cell.2017.03.035.
9
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.
10
Dynamics of mTORC1 activation in response to amino acids.
Elife. 2016 Oct 11;5:e19960. doi: 10.7554/eLife.19960.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验